A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer
A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer
Recruiting · NCT07361003 · Registry updated 2026-01-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 3 | 2026-01-22 | NCT07361003 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jiangsu Simcere Biologics Co., Ltd | 1 |
| Jiangsu Simcere Pharmaceutical Co., Ltd. | 24 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital of Shandong First Medical University | Jinan | China | 8 |
| Fujian Cancer Hospital | Fuzhou | China | 109 |
| Harbin Medical University University Cancer Hospital | Harbin | China | 1 |
| The First Affiliated Hospital of Nanjing Medical University | Nanjing | China | 43 |
| The Second Affiliated Hospital Zhejiang University School of Medicine | Hangzhou | China | 33 |
| Tianjin Medical University Cancer Institute and Hospital | Tianjin | China | 20 |